Health & Biotech
Respiri Limited (ASX: RSH) are an Australian owned company with smart tools to empower people with asthma and improve outcomes.
Backed by over twenty years of research by respiratory specialists, and with first-move advantage, Respiri offers an over-the-counter monitoring solution that will help people manage asthma in ways that have never been available before.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Respiri scores another key deal after joining forces with national telehealth platform Phenix; shares jump +50pc
Stockhead TV
Stock Talk: TeleHealth in a COVID-19 world and beyond
News
It was tough to raise capital in March unless you were a gold explorer
Tech
Health-tech company Respiri finds demand amid the chaos; closes $2m share placement
Tech
Remote control: 5 medtechs set to benefit from the surge in demand for tele-health solutions
Health & Biotech
Gone viral: COVID-19 is making Jatenergy, AuMake so very rich
Health & Biotech
Health: Zoono is not one to waste a crisis as epidemics beef up revenue
Health & Biotech
Health: Zelda wants to buy a private US-based medicinal cannabis company
Health & Biotech
Health: Respiri will begin a 4,500-bed trial of its ‘wheezo’ asthma device in India next month
Health & Biotech
Is asthma the next illness to watch?
Health & Biotech
Three Respiri board members have resigned ahead of its AGM tomorrow
Health & Biotech